$AstraZeneca (AZN.US)$
Breakthrough: First-Ever FDA-Approved Immunotherapy Shows 32% Better Outcomes in Bladder Cancer

$AstraZeneca (AZN.US)$
Major Breakthrough: AstraZeneca's TAGRISSO Extends Lung Cancer Survival to Nearly 5 Years

$AstraZeneca (AZN.US)$
ENHERTU Shows 38% Reduced Death Risk in Breast Cancer - EU Approval Now One Step Closer

$AstraZeneca (AZN.US)$
Can This Breakthrough Breast Cancer Drug Transform AstraZeneca's Oncology Portfolio?

$LumiraDx (LMDXF.US)$ if we started bringing awareness to X FB and other social media platforms we could probably win this fight. I stayed in Lumiradx because I figured if $AstraZeneca (AZN.US)$ had scooped it up we would have been jipped. $ROCHE HOLDING AG (RHHBY.US)$ seemed like a better fit as they have a plethora of innovative solutions to revitalize companies. 350m seems like an $Abbott Laboratories (ABT.US)$ or $Johnson & Johnson (JNJ.US)$ move to me and I don't buy it. Not from Roche.

$Sophia Genetics (SOPH.US)$ $AstraZeneca (AZN.US)$
Global Healthcare Revolution: Elite Hospitals Rush to Implement This Game-Changing Cancer Test

$AstraZeneca (AZN.US)$
Breakthrough in Bladder Cancer Treatment: AstraZeneca's IMFINZI Slashes Disease Progression Risk by 42%

$AstraZeneca (AZN.US)$
Groundbreaking Digital Adventure Helps Kids Master Their Rare Kidney Disease Journey

$AstraZeneca (AZN.US)$ $Compugen (CGEN.US)$
Major Breakthrough: AstraZeneca's New Weapon Against Early-Stage Lung Cancer Enters Final Testing

$LumiraDx (LMDXF.US)$ @BadPaint revisiting your Bill Gates post about him not selling his shares. It was announced while Lumiradx was on expert market I believe. Now I will say this, all the institutions that sold could have sold prior to expert market and bought back in during expert through an offshore entity. Zwanziger Ventures LLC perhaps? Can you dig more into Senvest for us?
Off topic here a bit however I found this intriguing that Cobas was introduced in '94 however Roche only started divi...